Terms: = Breast cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Clinical Outcome
4 results:
1. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract] [Full Text] [Related]
2. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract] [Full Text] [Related]
3. Complex formation and function of estrogen receptor α in transcription requires RIP140.
Rosell M; Nevedomskaya E; Stelloo S; Nautiyal J; Poliandri A; Steel JH; Wessels LF; Carroll JS; Parker MG; Zwart W
Cancer Res; 2014 Oct; 74(19):5469-79. PubMed ID: 25145671
[TBL] [Abstract] [Full Text] [Related]
4. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.
Zwart W; Theodorou V; Kok M; Canisius S; Linn S; Carroll JS
EMBO J; 2011 Oct; 30(23):4764-76. PubMed ID: 22002538
[TBL] [Abstract] [Full Text] [Related]